Indietro

Oral Communication

What is left to say on COVID-19 today?

OC 58
Inflammatory milieu and specific T cells response after three months and one year from SARS-CoV-2 infection
Abstract
OC 59
Clinical features and impact on mortality of COVID-19 epidemics in patients with Non-Hodgkin lymphoma: long-term results from a tertiary center in Italy
Abstract
OC 60
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active hematological disease undergoing off-label combined antiviral treatments
Abstract
OC 61
SARS-CoV-2 intra-host evolution during acute infection in COVID-19 patients
Abstract
| Privacy policy | Cookies policy | Termini e condizioni di utilizzo |
© Effetti srl
P. IVA 10756900154
×

Commento audio

Chiudi